BMY vs VSTD · P/E 17, rev $48.19B vs rev $12.8M
Bristol-Myers Squibb Company (BMY) versus Vestand Inc. (VSTD) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Vestand Inc. (VSTD) is a restaurants company listed on NASDAQ.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported VSTD revenue for 2024-12-31 was $12.8M. Net income was -$2.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. VSTD currently screens at market cap $4.5M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. VSTD currently screens at market cap $4.5M.
Not investment advice. Open the BMY and VSTD stock pages for the full models.
Not investment advice.